Now Reading
Alkermes Proudly Announces Release of 2023 Corporate Responsibility Report
Alkermes Proudly Announces Release of 2023 Corporate Responsibility Report
Published 10-12-23
Submitted by Alkermes
Corporate responsibility is foundational to our business. We are proud to release our latest Corporate Responsibility Report, which details our progress in 2022 related to environmental sustainability, diversity, inclusion and belonging and ethical governance. Read the full report: https://www.alkermes.com/responsibility#csr
Alkermes
Alkermes
Alkermes plc is a fully-integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience and oncology. The company has a portfolio of proprietary commercial products focused on alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurological disorders and cancer. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes' website at www.alkermes.com.
More from Alkermes
